Delivery Order SPE2DB22D3301-SPE2DB24FY6RA
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Gilenya 0.5 mg capsule 30s, with a ceiling value of $48,930.98 and a completion date of June 9, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The delivery order contract, valued at $5,873.20, is for the supply of Gilenya 0.5 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of July 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gilenya 0.5 mg capsules. The fixed-price contract has a ceiling value of $16,277.28 and a period of performance through May 12, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,359.88 firm-fixed-price contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication. The award has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for providing a comprehensive range of medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) on May 7, 2025. The $43,935.58 firm fixed-price delivery order is for the provision of the medication Gilenya 0.5 mg capsules, with a performance period extending to May 8, 2025. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which allows the company...
- This federal contract award, valued at $42,038.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of Gilenya 0.5 mg capsules. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of essential medical products and prescription drugs to various government agencies and healthcare programs. This delivery order contract has a firm-fixed price and a completion date of August...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,271.58 firm-fixed-price delivery order is for the supply of Gilenya 0.5 mg capsules and has an ultimate completion date of May 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $26,277.64 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $14,892.74, is for the delivery of Gilenya 0.5 mg capsules. This is a firm-fixed price delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical. The IDC enables the DLA to efficiently procure a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Gilenya 0.5 mg capsules. The Firm Fixed Price delivery order, valued at $8,571.37, has a completion date of February 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY6RADelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,054.04, is for the supply of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a firm fixed price and is set to expire on May 14, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.1k | 5/13/24 |